5-aminolevulinic acid hydrochloride

DRUG2 trials

Sponsors

Miyake Makito, Icahn School of Medicine at Mount Sinai

Conditions

Localized upper urinary tract cancer (renal pelvic cancer and ureteral cancer) Urothelial carcinoma, Upper urinary tract cancer, renal pelvic cancer, ureteral cancerNeoplasmSkull Base Neoplasm

Phase 2

Fluorescence ureteroscopy-assisted transurethral surgery with oral 5-aminolevulinic acid for upper urinary tract tumor

Active, not recruitingJPRN-jRCTs051210042

Miyake MakitoLocalized upper urinary tract cancer (renal pelvic cancer and ureteral cancer) Urothelial carcinoma, Upper urinary tract cancer, renal pelvic cancer, ureteral cancer

Start: 2021-06-28Target: 20Updated: 2026-06-29

The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial

TerminatedNCT05101798

Icahn School of Medicine at Mount SinaiNeoplasm, Skull Base Neoplasm

Start: 2021-09-14End: 2022-12-25Updated: 2025-07-28

Related Papers

A prospective, single-arm trial of fluorescent ureteroscopy-assisted thulium-holmium:YAG dual laser ablation for upper urinary tract cancer: Study protocol of the FLUAM trial.

2022-03-025 citations